SCHEMBL1305583

SCHEMBL1305583

O=C1C=CCC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28001381 0.97
Piperazine SCHEMBL28233038 0.89 GSK3A (0.36)
SCHEMBL5390716 0.76
SCHEMBL26294821 0.74
SCHEMBL10909121 0.74
SCHEMBL20206954 0.74
SCHEMBL11134523 0.74 GSK3A (0.41)
SCHEMBL11134519 0.74 TDP2 (0.30)
SCHEMBL14315764 0.71 CRBN (0.42)
SCHEMBL11190350 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 591 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025016351-A1 COMPOUND BASED ON THIO-GLUTARIMIDO ISOINDOLINONE SKELETON AND USE THEREOF 标新生物医药科技(上海)有限公司 2025-01-23 WO claimed
CN-113767092-B Di-heterocyclic carbonyl substituted dihydropyrazoles, their preparation and their use in medicine 劲方医药科技(上海)有限公司 2024-07-16 CN claimed
CN-115551867-B Fused tricyclic compounds, pharmaceutical compositions and uses thereof 劲方医药科技(上海)有限公司 2024-02-20 CN claimed
WO-2023151635-A1 COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF 标新生物医药科技(上海)有限公司 2023-08-17 WO claimed
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 WO claimed
WO-2023066350-A1 CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS 标新生物医药科技(上海)有限公司 2023-04-27 WO claimed
EP-4159739-A1 FUSED TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF Genfleet Therapeutics (Shanghai) Inc. (CN) 2023-04-05 EP claimed
WO-2023284703-A1 PROTEIN DEGRADATION COMPOUND DESIGNED ON THE BASIS OF BRUTON'S TYROSINE KINASE LIGAND AND APPLICATION THEREOF 标新生物医药科技(上海)有限公司 2023-01-19 WO claimed
CN-115551867-A Fused tricyclic compound, pharmaceutical composition and application thereof 劲方医药科技(上海)有限公司 2022-12-30 CN claimed
CN-113767092-A Bis-heterocyclic carbonyl substituted dihydropyrazole compound, preparation method and medical application thereof 劲方医药科技(上海)有限公司 2021-12-07 CN claimed
US-7132229-B2 Photothermographic material and image forming method FUJI PHOTO FILM CO., LTD (JP) 2006-11-07 US claimed
US-20060019207-A1 Photothermographic material and image forming method FUJIFILM CORPORATION (JP) 2006-01-26 US claimed
WO-2005116008-A1 PROCESS FOR PRODUCING PIPERIDIN-2,6-DIONES HETEROCYCLICALLY SUBSTITUTED AT POSITION 3 Grünenthal GmbH (DE) 2005-12-08 WO claimed
EP-1456197-A1 PIPERIDINE-2,6-DIONES THAT ARE HETEROCYCLICALLY SUBSTITUTED IN POSITION 3 Grünenthal GmbH (DE) 2004-09-15 EP claimed
EP-1042315-B1 CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE CO CHEM PHARM FAB (DE) 2004-04-14 EP claimed
WO-2003053956-A1 PIPERIDINE-2,6-DIONES THAT ARE HETEROCYCLICALLY SUBSTITUTED IN POSITION 3 Grünenthal GmbH (DE) 2003-07-03 WO claimed
EP-1042315-A1 CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS Klinge Pharma GmbH (DE) 2000-10-11 EP claimed
WO-1999031087-A1 CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE PHARMA GMBH (DE) 1999-06-24 WO claimed
US-5346810-A Oxonol dye which is decolored by development FUJI PHOTO FILM CO., LTD. (JP) 1994-09-13 US claimed
EP-0552646-A1 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1993-07-28 EP claimed